,
Ouzan, Denis
Larrey, Dominique
Guyader, Dominique
Remy, André-Jean
Riachi, Ghassan
Heluwaert, Fréderic
Truchi, Régine
Combis, Jean-Marc
Bailly, François
Rosa, Isabelle
Hézode, Christophe
Glorian-Petraud, Denise
Libert, Olivier
Ramroth, Heribert
Asselah, Tarik
Thiefin, Gérard
Roulot, Dominique
Roche, Bruno
Leroy, Vincent
Dumortier, Jérôme
Thabut, Dominique
Pol, Stanislas
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 24 September 2018
Accepted: 24 March 2020
First Online: 18 April 2020
Compliance with Ethical Standards
:
: Denis Ouzan has served as a speaker for AbbVie and Gilead Sciences, reports research funding from Gilead Sciences, and reports financial support for attending symposia and sponsorship for educational meetings from AbbVie, Gilead Sciences and Merck Sharp & Dohme. Dominique Larrey has served as a speaker/advisor for AbbVie, Gilead Sciences and Merck Sharp & Dohme. Dominique Guyader has served as a speaker for and reports financial support for attending symposia from AbbVie, Gilead Sciences, Merck Sharp & Dohme, and Janssen, and also reports research funding from Janssen. André-Jean Remy has served as a speaker/consultant/advisor for Gilead Sciences. Ghassan Riachi has served as a speaker and advisor for Gilead Sciences. Fréderic Heluwaert, Jean-Marc Combis, Isabelle Rosa, Dominique Roulot, Bruno Roche and Jérôme Dumortier have no conflicts of interest to declare. Régine Truchi has served as a speaker and clinical investigator for Gilead Sciences. François Bailly has served as a speaker/advisor for AbbVie, Bristol-Myers Squibb, Gilead Sciences and Merck Sharp & Dohme, and reports financial support for attending symposia from AbbVie, Gilead Sciences and Merck Sharp & Dohme. Christophe Hézode, Denise Glorian-Petaud, Olivier Libert and Heribert Ramroth is an employee of Gilead Sciences. Tarik Asselah has served as a clinical investigator and speaker for AbbVie, Gilead Sciences, Janssen and Merck Sharp & Dohme. Gérard Thiefin has served as a speaker for and reports financial support for attending symposia from Gilead Sciences. Vincent Leroy has served as a speaker/advisor and clinical investigator for Gilead Sciences. Dominique Thabut reports financial support for attending symposia from AbbVie and Gilead Sciences. Stanislas Pol has served as a speaker/consultant for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme, and Roche, and reports research funding from Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, and Roche.